Modified-release dosage forms
Feldmann, E.G.
American Journal of Hospital Pharmacy 43(10): 2565-2566
1986
ISSN/ISBN: 0002-9289 PMID: 3789000 Document Number: 280944
Document emailed within 1 workday
Related Documents
Sznitowska, M.łg.; Cal, K.; Kupiec, K. 2004: Development of modified-release dosage forms containing loratadine and pseudoephedrine sulfate Acta Poloniae Pharmaceutica 61 Suppl: 72-74Balant, L.P. 1993: Regulatory aspects of modified release dosage forms: clinical studies Bollettino Chimico Farmaceutico 132(5): 143-149
Siewert, M. 1993: Regulatory aspects of modified release dosage forms: in vivo/in vitro correlations Bollettino Chimico Farmaceutico 132(1): 10-22
Möller, H.; Wirbitzki, E. 1993: Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system Bollettino Chimico Farmaceutico 132(4): 105-115
Gurny, R.; Buri, P.; Sucker, H.; Guitard, P.; Leuenberger, H. 1977: Production and theoretical development of dosage forms having release controlled by metacrylic films. 4. Multiple linear regression study of technological factors influencing the release of an active principle from microgranules encased by fluidization Pharmaceutica Acta Helvetiae 52(10): 247-251
Lin, S.Y.; Yang, J.C. 1989: In-vitro dissolution behavior of some sustained-release theophylline dosage forms Pharmaceutica Acta Helvetiae 64(8): 236-240
Skelly, J.P.; Van Buskirk, G.A.; Savello, D.R.; Amidon, G.L.; Arbit, H.M.; Dighe, S.; Fawzi, M.B.; Gonzalez, M.A.; Malick, A.W.; Malinowski, H. 1993: Scale-up of immediate release oral solid dosage forms. AAPS/FDA Workshop Committee Report Journal of parenteral science and technology: a publication of the Parenteral Drug Association 47(2): 52-56
Förster, H.; Lippold, B.C. 1982: Conception of peroral sustained-release dosage forms: calculation of initial and maintenance dose with consideration of accumulation Pharmaceutica Acta Helvetiae 57(12): 345-349
Brock, M.H.; Dansereau, R.J.; Patel, V.S. 1994: Use of in vitro and in vivo data in the design, development, and quality control of sustained-release decongestant dosage forms PharmacoTherapy 14(4): 430-437
Trautlein, J.J.; Demers, L.; Esler, V.; Field, E. 1981: Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma Clinical Therapeutics 4(4): 252-262
Vattikonda, C.S.; Ritschel, W.A.; Herbert, C. 1994: Biopharmaceutic approach in designing a controlled release tablet of sodium monofluoro phosphate. Characterization of absorption sites and evaluation of modified dosage form International Journal of Clinical Pharmacology and Therapeutics 32(10): 559-566
Huynh-Ngoc, T.; Sirois Gérard 1977: Evaluation of a continuous fluid exchange system in the USP basket-stirrer dissolution test assembly. Part 11: Characterization of the dissolution profile of quinidine sustained-release dosage forms Journal de Pharmacie de Belgique 32(1): 67-75
Kaewpornsawan, K.; Khuntisuk, S.; Jatunarapit, R. 2007: Comparison of modified posteromedial release and complete subtalar release in resistant congenital clubfoot: a randomized controlled trial Journal of the Medical Association of Thailand 90(5): 936-941
Mastropasqua, F.; Totaro, P.; Massari, F.; Pitzalis, M.V.; Rizzon, P. 1998: Double-blind randomized placebo-controlled study of the effects of slow release and immediate release forms of propafenone in patients ventricular extrasystole symptoms Cardiologia 43(6): 617-623
Liou, J-Ming.; Chen, C-Yi.; Wu, M-Shiang.; Hsu, M-Tse.; Fang, C-Chung.; Lin, Y-Ling.; Chang, M-Chu.; Lin, J-Town.; Wang, H-Po. 2006: Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease Hepato-Gastroenterology 53(71): 792-796
Willems, P.; Sørensen, E.W.; Hansen, T.S.; Byg, R. 1988: Drugs--dosage forms Sygeplejersken 88(31): 4-7
Ritschel, W.A. 1973: Bioavailability of peroral dosage forms Bollettino Chimico Farmaceutico 112(3): 137-162
Sobiczewska, M.; Borkowski, B. 1970: Determination of ajmaline in dosage forms Die Pharmazie 25(5): 334-335
Zecca, L.; Ferrario, P.; Pirola, R.; Reina, L.; Zambotti, F.; Zonta, N.; Lepore, A.M.; Scaglione, F.; Fraschini, F. 1989: Pharmacokinetics of buflomedil after various dosage forms Arzneimittel-Forschung 39(4): 518-519
Helliwell, M.; Taylor, D. 1993: Solid oral dosage forms Professional Nurse 8(5): 313-317